Edition:
United States

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

4.99USD
14 Dec 2017
Change (% chg)

$-0.21 (-4.04%)
Prev Close
$5.20
Open
$5.13
Day's High
$5.13
Day's Low
$4.99
Volume
2,954
Avg. Vol
6,760
52-wk High
$10.75
52-wk Low
$3.04

Summary

Name Age Since Current Position

Avner Rotman

74 2005 Chairman of the Board

Ron Babecoff

54 2003 Chief Executive Officer, President, Director

Uri Ben-Or

47 2007 Chief Financial Officer

Tamar Ben-Yedidia

53 2004 Chief Scientific Officer

Yisrael Gewirtz

40 2014 Internal Auditor

George Lowell

72 2008 Director

Ori Mor

46 2016 Director

Jack Rosen

71 2013 Director

Irit Ben-Ami

56 2008 External Director

Ruth Ben Yakar

47 Independent Director

Michal Marom-Brikman

48 2015 Independent Director

Biographies

Name Description

Avner Rotman

Prof. Avner Rotman serves as Chairman of the Board of Directors at Biondvax Pharmaceuticals Ltd since 2005. His work experience includes the following roles: Founder, Chief Executive Officer and Chairman of the Board of Directors of Rodar Technologies Ltd (since 2000), Founded (1984), President and Chief Executive Officer of Bio-Dar Ltd (1985-2000), Chairman of I-Tech incubator in Kyriat Weizmann and Founder and Chairman of the Foundation of Cardiovascular Research in Israel. Prof. Rotman holds a Bachelor of Science degree and a Master of Science degree in Chemistry from The Hebrew University of Jerusalem and a Doctorate of Science degree from the Weizmann Institute of Science.

Ron Babecoff

Dr. Ron Babecoff serves as Chief Executive Officer, President and Director at Biondvax Pharmaceuticals Ltd since 2003. He Co-Founded the Company in 2003 and has led it since its inception. His work experience also includes the role of Marketing Manager at Omrix Biopharmaceuticals Ltd (2000-2003). Dr. Babecoff holds a Doctorate of Medicine degree in Veterinary Medicine (DVM) from Universite de Liège, Belgium and a Masters degree in Entrepreneurship and Innovation (MEI) from Swinburne University of Technology of Melbourne, Australia.

Uri Ben-Or

Mr. Uri Ben-Or serves as Chief Financial Officer at Biondvax Pharmaceuticals Ltd since June 20, 2007. He serves and has served as Vice President - Finance at a variety of companies and provides financial services through his own company (called CFO Direct). He holds a Bachelor of Business Administration degree and a Masters degree in Accounting, both from Hamichlala Leminhal and a MBA degree from Bar Ilan University. He is a Certified Public Accountant.

Tamar Ben-Yedidia

Dr. Tamar Ben-Yididia serves as Chief Scientific Officer at Biondvax Pharmaceuticals Ltd since 2004. Her work experience includes the following roles: Lab Manager at Biotechnology General (Israel) Ltd (1991-1994) and Research Associate at Weizmann Institute of Science-Department of Immunology (1994-2004). Dr. Ben-Yedidia was involved in two European Consortium projects related to the evaluation of different approaches for vaccination, has been invited to address conferences worldwide. Dr. Ben-Yedidia holds a Bachelor of Science degree and a Master of Science degree, both in Life Sciences from Tel-Aviv University and a Doctorate of Science degree in Immunology from Weizmann Institute of Science. Her Doctoral Thesis is titled "A Peptide-Based Vaccine Against Influenza".

Yisrael Gewirtz

Mr. Yisrael Gewirtz serves as Internal Auditor at Biondvax Pharmaceuticals Ltd since October 22, 2014. His work experience includes a Partner role at a private Accountancy firm. Mr. Gewirtz holds a Bachelors degree in Accounting and Economics from Bar Ilan University. He is a Certified Chartered Accountant.

George Lowell

Prof. George H. Lowell serves as Director at Biondvax Pharmaceuticals Ltd since 2008. Prof. Lowell's work experience includes the following roles: Chief Scientific Officer for BioDefense at GlaxoSmithkline Biologicals (2006-2007), Chief Scientific Officer at ID Biomedical Corp. (2001-2006), Founder and Chief Scientific Officer of Intellivax, Inc (Baltimore) and Intellivax International Inc. (Montreal; vaccine R&D companies; 1995-2001), retired Colonel from the US Army Medical R&D Command (1974-1994)-where he served as Consultant for pediatric infectious diseases at The Walter Reed Army Medical Center and Director of laboratories at The Walter Reed Army Institute of Research in Washington, D.C., Visiting Scientist at the Weizmann Institute of Science (Israel) and Visiting Professor, Hebrew University-Hadassah Medical Center. Prof. Lowell holds a Bachelor of Arts degree from Yeshiva University and a Doctorate of Medicine degree from Albert Einstein College of Medicine, NY.

Ori Mor

Mr. Ori Mor serves as Director at Biondvax Pharmaceuticals Ltd since 2016. His work experience includes the following roles: Director at a variety of companies, Founder of and Chief Executive Officer at his own Consultancy firm (from 2012) and Vice President – Finance at Medical Compression Systems (2009-2014). He holds a Bachelors degree in Economics and Business Administration and a Masters degree in Economics, both from Ben Gurion University.

Jack Rosen

Mr. Jack Rosen serves as Director at Biondvax Pharmaceuticals Ltd since June 30, 2013. He is a member of the Audit and Compensation committees. His work experience includes the following roles: Chairman of the American Jewish Congress (2005-2012), President of the American Jewish Congress (1996-2005 and since 2012), Chairman of the American Council for World Jewry, Inc. (since 2004), Founder of Rosen Partners LLC (real estate development firm; 2002), Chief Executive Officer at Rosen Partners LLC, Director at Fusion Telecommunications International, Inc, Director at NextWave Wireless Inc (2005-2013), Member of the Advisory Board of Altimo (2007-2013) and Member on NASA Advisory Council. He holds a Bachelor of Science degree in Mathematics from City University of New York.

Irit Ben-Ami

Ms. Irit Ben-Ami serves as External Director at Biondvax Pharmaceuticals Ltd since 2008. She is the Chairwoman of the Audit and Compensation committees. Her work experience includes the following roles: Founding Partner of Pitaro-Ben Ami Attorneys, Member of The Institute of Certified Public Accountants in Israel and of the Israel Bar Association, Director at a variety of companies, She holds a Bachelors degree in Accounting and Economics from Haifa University, a LLB degree from Sha’arei Mishpat – The College of Legal Studies, a Masters degree in Health Systems Management from Ben Gurion University and a Master of Legal Letters degree from The Interdisciplinary Center (IDC) Herzliya.

Ruth Ben Yakar

Dr. Ruth Ben Yakar serves as Independent Director at Biondvax Pharmaceuticals Ltd. Her work experience includes the following roles: Chief Executive Officer at BioSight, Chief Executive Officer at Procognia (Israel) Ltd (two years), Vice President-Projects Management at Gamida Cell (two years), Chief Business Officer at YEDA (The Technology Transfer Company of Weizmann Institute of Science; two years), Director at Cellect Biotechnology Ltd and Director at IATI-Israel Advance Technologies Industries. Dr. Ben Yakar holds a Bachelor of Science degree in Biology from Tel Aviv University and a Doctorate of Science degree in Molecular Biology from Weizmann Institute of Science.

Michal Marom-Brikman

Ms. Michal Marom-Brikman serves as Independent Director at Biondvax Pharmaceuticals Ltd since May 20, 2015. She is a member of the Audit and Compensation committees. Her work experience includes the following roles: Chief Financial Officer at Dan Hotels Ltd (2008-2011), Chief Financial Officer of Linkury Ltd (2011-2014) and Director at a variety of companies. She holds a Bachelors degree in Accounting and Business Management from Hamichlala Leminhal and a Masters degree in Finance from Baruch College, City University of New York. She is a Certified Chartered Accountant.

Basic Compensation